Detection of AQP4-specific autoantibodies (AQP4-IgG, also known as NMO-IgG) in patients’ serum is crucial for diagnosing NMO and distinguishes it from multiple sclerosis (MS) (1). The gene discussed is AQP4; the disease is myeloid sarcoma.